Insider trades
Luke Evnin, Director of Werewolf Therapeutics HOWL, has filed 1 purchase and 90 sales on the open market. Over the past 12 months that comes to a net purchase of $16.8M. The latest trade was on 06/29.
Luke Evnin
Director
- Company
- Werewolf Therapeutics HOWL
- First filing
- 23/05/24
- Trades
- 107 trades
- Buys / sales
- 1 / 90
- 12-month net buying
- $16.8M
- Last trade
- 06/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/29 | 06/29 | 157,084 sh | $0.30 | $47,125.2 | −52.3% | |
| Open-market sale10b5-1 plan | 06/09 | 06/10 | 76,928 sh | $0.37 | $28,463.36 | −20.4% | |
| Open-market sale10b5-1 plan | 06/04–06/08 | 06/08 | 105,565 sh3 trades | $0.41avg. | $43,028.88 | −21.9% | |
| Open-market sale10b5-1 plan | 06/01–06/03 | 06/03 | 139,803 sh3 trades | $0.46avg. | $63,628.06 | −22.5% | |
| Open-market sale10b5-1 plan | 05/27–05/29 | 05/29 | 141,106 sh3 trades | $0.47avg. | $66,200.24 | −18.5% | |
| Open-market sale10b5-1 plan | 05/21–05/26 | 05/26 | 191,762 sh3 trades | $0.45avg. | $86,560.29 | −20.1% | |
| Open-market sale10b5-1 plan | 05/18–05/20 | 05/20 | 171,049 sh3 trades | $0.45avg. | $76,363.35 | −15.2% | |
| Open-market sale10b5-1 plan | 05/13 | 05/13 | 44,679 sh | $0.54 | $24,126.66 | −3.8% | |
| Open-market sale10b5-1 plan | 05/08–05/12 | 05/12 | 407,574 sh3 trades | $0.69avg. | $280,210.26 | −25.8% | |
| Open-market sale10b5-1 plan | 05/05–05/07 | 05/07 | 100,581 sh3 trades | $0.64avg. | $64,216.68 | −6.0% | |
| Open-market sale10b5-1 plan | 04/30–05/04 | 05/04 | 274,619 sh3 trades | $0.72avg. | $198,309.62 | −14.1% | |
| Open-market sale10b5-1 plan | 04/27–04/29 | 04/29 | 205,911 sh3 trades | $0.75avg. | $154,525.47 | −9.5% | |
| Open-market sale10b5-1 plan | 01/16 | 01/20 | 38,782 sh | $0.54 | $20,942.28 | −1.8% | |
| Open-market sale10b5-1 plan | 01/13–01/15 | 01/15 | 111,227 sh3 trades | $0.56avg. | $61,787.17 | −4.8% | |
Aktis OncologyAKTS | Open-market buy | 01/12 | 01/14 | 1,112,777 sh | $18.00 | $20,029,986 | +12.2% |
| Open-market sale10b5-1 plan | 01/08–01/12 | 01/12 | 91,374 sh3 trades | $0.59avg. | $53,533.26 | −3.8% | |
| Open-market sale10b5-1 plan | 01/05–01/07 | 01/07 | 71,054 sh3 trades | $0.65avg. | $45,882.17 | −2.9% | |
| Open-market sale10b5-1 plan | 25/12/30–01/02 | 01/02 | 78,377 sh3 trades | $0.62avg. | $48,430.95 | −3.1% | |
| Open-market sale10b5-1 plan | 25/12/22–25/12/29 | 25/12/29 | 291,283 sh5 trades | $0.64avg. | $185,220.79 | −10.2% | |
| Open-market sale10b5-1 plan | 25/12/15–25/12/17 | 25/12/17 | 48,171 sh3 trades | $1.08avg. | $51,950.82 | −1.7% |